EUVIMEDEUVIMED entdecken
Crossref

FGF-23 regulates MMP-14 expression and angiogenesis via the p85/Akt/mTOR signaling pathway in osteosarcoma

Chun-Han Hou, Chih-Yang Lin

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Chun-Han Hou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, National Taiwan University Hospital, No. 1, Jen-Ai Road, Taipei 100, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, Matrix Metalloproteinase 14, Fibroblast Growth Factors, Neovascularization, Pathologic. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Taiwan University Hospital, Shin Kong Wu Ho Su Memorial Hospital, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma is a highly aggressive bone malignancy in which angiogenesis plays a crucial role in tumor progression. However, the molecular mechanisms underlying osteosarcoma-associated angiogenesis remain incompletely understood. In this study, we investigated the role of fibroblast growth factor-23 (FGF-23) in regulating angiogenesis in osteosarcoma. Bioinformatics analysis of the GSE218035 dataset revealed that matrix metalloproteinases (MMPs), particularly MMP-14, are significantly upregulated in osteosarcoma tissues. Functional assays demonstrated that FGF-23 induces MMP-14 expression in osteosarcoma cells and enhances endothelial tube formation, whereas silencing MMP-14 abolishes these effects. Mechanistic studies further showed that FGF-23 activates the p85/Akt/mTOR signaling pathway, leading to increased MMP-14 expression and angiogenic activity. Inhibition of pathway components by pharmacological inhibitors or siRNA significantly attenuated FGF-23-induced responses. In vivo, FGF-23 overexpression promoted tumor growth and vascularization, accompanied by elevated expression of MMP-14 and the endothelial marker CD31. Collectively, these findings demonstrate that FGF-23 promotes osteosarcoma angiogenesis through regulation of MMP-14 via the p85/Akt/mTOR signaling pathway and suggest that targeting this axis may provide a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaMatrix Metalloproteinase 14Fibroblast Growth FactorsNeovascularization, PathologicBone NeoplasmsHumansTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionAnimalsFibroblast Growth Factor-23MiceCell ProliferationMice, Nude

Stichwörter der Autor:innen

AngiogenesisFGF-23MMP-14Osteosarcoma

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMatrix Metalloproteinase 14Fibroblast Growth FactorsFibroblast Growth Factor-23MTOR protein, humanFGF23 protein, humanMMP14 protein, human

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, National Taiwan University Hospital, No. 1, Jen-Ai Road, Taipei 100, Taiwan.
  • Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404327, Taiwan. Electronic a…

Förderung

  • National Taiwan University Hospital
  • Shin Kong Wu Ho Su Memorial Hospital
  • National Science and Technology Council

Zitieren

APA

Hou, C. H., & Lin, C. Y. (2026). FGF-23 regulates MMP-14 expression and angiogenesis via the p85/Akt/mTOR signaling pathway in osteosarcoma. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110265

Vancouver

Hou CH, Lin CY. FGF-23 regulates MMP-14 expression and angiogenesis via the p85/Akt/mTOR signaling pathway in osteosarcoma. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110265

BibTeX
@article{Hou2026,
  author = {Hou, Chun-Han and Lin, Chih-Yang},
  title = {FGF-23 regulates MMP-14 expression and angiogenesis via the p85/Akt/mTOR signaling pathway in osteosarcoma},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110265}
}
Kostenlos starten →